Cardiovascular Drugs Practice Questions

Q: Drug used for both the acute angina attack and prophylaxis of angina:

Isosorbide dinitrate. ***Isosorbide dinitrate***- This drug is a **nitrate** available in multiple formulations that can be used for **both acute relief and prophylaxis of angina** [1].- **Sublingual isosorbide dinitrate** has a rapid onset (2-5 minutes) making it suitable for **acute angina attacks**, while **oral formulations** provide longer duration of action for **prophylactic management** [1].- It works by causing **vasodilation**, primarily of veins, reducing **preload** and myocardial oxygen demand, and also dilates coronary arteries.- This dual-use capability through different formulations makes it unique among the given options.*Diltiazem*- Diltiazem is a **calcium channel blocker** primarily used for the **prophylaxis of angina** by reducing heart rate and myocardial contractility [2].- While effective for prevention, its onset of action is **too slow for acute angina relief**.*Verapamil*- Verapamil, another **calcium channel blocker**, is also used for **angina prophylaxis** due to its effects on reducing heart rate and contractility.- Similar to diltiazem, it is **not suitable for acute angina attacks** because it does not provide rapid relief.*Dipyridamole*- Dipyridamole is a **vasodilator** and a **platelet aggregation inhibitor**, primarily used in the prevention of thromboembolic events or as a pharmacologic stress agent.- Although it causes vasodilation, it is **not recommended for acute angina relief** or as a primary prophylactic agent for angina due to the risk of **coronary steal phenomenon** in some patients.

Q: Which medication is a selective beta-1 adrenergic blocker commonly used as a first-line treatment for hypertension?

Atenolol. ***Atenolol*** - **Atenolol** is a **selective beta-1 adrenergic blocker** [2], [4] that primarily blocks beta-1 receptors in the heart, reducing heart rate and contractility [3]. - Its **cardioselectivity** makes it a preferred first-line treatment for hypertension [1] due to fewer peripheral side effects compared to non-selective beta-blockers [3]. *Nor adrenaline* - **Noradrenaline** (norepinephrine) is a **sympathomimetic catecholamine** that primarily acts on alpha-1 and beta-1 adrenergic receptors, causing vasoconstriction and increased heart rate. - It is used in conditions like **septic shock** to raise blood pressure, not to treat chronic hypertension. *Dopamine* - **Dopamine** is a **catecholamine** with dose-dependent effects; low doses stimulate D1 receptors causing renal vasodilation, while higher doses stimulate beta-1 and alpha-1 receptors. - Its primary use is to treat **shock** and improve renal perfusion, not as a first-line antihypertensive. *Epinephrine* - **Epinephrine** (adrenaline) is a potent **vasoconstrictor** and **bronchodilator** that acts on alpha and beta adrenergic receptors, increasing heart rate, contractility, and blood pressure. - It is primarily used in **anaphylaxis** and cardiac arrest, not for chronic management of hypertension.

Q: Which of the following drugs is most classically associated with the coronary steal phenomenon?

Dipyridamole. ***Dipyridamole*** - **Dipyridamole** is a potent vasodilator that preferentially dilates healthy coronary arteries, diverting blood flow away from stenosed, ischemic areas. - This shunting of blood, known as the **coronary steal phenomenon**, can worsen ischemia in patients with coronary artery disease and is the basis of its use in cardiac stress testing. *Nitrates* - **Nitrates** primarily cause venodilation, reducing preload and myocardial oxygen demand, while also promoting epicardial coronary vasodilation. - While they can redistribute blood flow, they are generally used to treat angina and are not classically associated with the worsening of ischemia through a typical "steal" mechanism in the same way as dipyridamole. *Nifedipine* - **Nifedipine** is a dihydropyridine calcium channel blocker that causes peripheral and coronary vasodilation. - While it can lower blood pressure and improve coronary blood flow, it is not primarily associated with the **coronary steal phenomenon**; in fact, it can be used to treat myocardial ischemia. *Nicorandil* - **Nicorandil** is a potassium channel opener with nitrate-like properties, causing both arterial and venous dilation. - It works by reducing preload and afterload and directly dilating coronary arteries, making it beneficial for angina, rather than causing a coronary steal phenomenon.

Q: A 55-year-old patient with dyslipidemia and elevated LDL cholesterol is at increased risk of ischemic stroke. Which of the following is the most appropriate treatment to lower LDL cholesterol and reduce stroke risk?

Statins (HMG-CoA reductase inhibitors). ***Statins (HMG-CoA reductase inhibitors)*** - **Statins** are the first-line therapy for **dyslipidemia** due to their significant efficacy in lowering **LDL cholesterol** and their proven benefit in reducing the risk of **cardiovascular events**, including **ischemic stroke**. - They work by inhibiting **HMG-CoA reductase**, a key enzyme in **cholesterol synthesis** in the liver, which leads to increased **LDL receptor** expression and uptake of **LDL from the blood**. *Fibric acid derivatives* - **Fibric acid derivatives** (fibrates) primarily lower **triglycerides** and can modestly increase **HDL cholesterol**, but their effect on **LDL cholesterol** reduction is less pronounced than statins. - While they may reduce overall cardiovascular risk, they are not as effective as statins for primary **LDL-C lowering** and **stroke prevention** in patients with high LDL. *Nicotinic acid (niacin)* - **Niacin** can lower **LDL cholesterol**, triglycerides, and significantly increase **HDL cholesterol**; however, its use is limited by common side effects such as **flushing** and **pruritus**. - Clinical trials have not consistently shown that niacin provides additional cardiovascular benefit when added to statin therapy, and its primary role is not for aggressive **LDL-C reduction** in patients at high stroke risk. *Bile acid sequestrants* - **Bile acid sequestrants** (resins) lower **LDL cholesterol** by binding to bile acids in the intestine, preventing their reabsorption and promoting their excretion, which forces the liver to use more cholesterol to make new bile acids. - They are less potent than statins in lowering **LDL-C**, often cause gastrointestinal side effects like **constipation** and **bloating**, and are generally considered second-line or adjunctive therapy for **LDL reduction**.

Q: Which of the following statements about Tadalafil is incorrect?

It cannot be used for the treatment of PAH. ***It cannot be used for the treatment of PAH*** - This statement is incorrect because **Tadalafil** (Adcirca®) is, in fact, approved and commonly used for the treatment of **pulmonary arterial hypertension (PAH)**, as it causes vasodilatation in the pulmonary vasculature. - It works by inhibiting phosphodiesterase-5 (PDE5), leading to increased **cGMP** levels and smooth muscle relaxation in the pulmonary arteries. *It is longest acting phosphodiesterase inhibitor* - This statement is correct. **Tadalafil** has the longest duration of action among the PDE5 inhibitors, with effects lasting up to 36 hours, hence its nickname "the weekend pill." - This extended duration is due to its longer half-life compared to other PDE5 inhibitors like sildenafil or vardenafil. *It is used in erectile dysfunction* - This statement is correct. **Tadalafil** (Cialis®) is widely prescribed for the treatment of **erectile dysfunction (ED)** due to its ability to improve erectile function. - It enhances the effects of nitric oxide, leading to relaxation of penile smooth muscle and increased blood flow necessary for an erection. *Its half life is 17.5 hours* - This statement is correct. The relatively **long half-life of 17.5 hours** is a key pharmacological feature of tadalafil contributing to its prolonged duration of action. - This extended half-life allows for once-daily dosing in some indications and a longer therapeutic window for on-demand use.

Q: For a patient diagnosed with dyslipidemia characterized by elevated LDL cholesterol levels, what is the most appropriate treatment?

Statins. ***Statins*** - **Statins** are the frontline treatment for elevated **LDL cholesterol**, significantly reducing **cardiovascular risk** by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. - They effectively **lower LDL levels** and have additional **pleiotropic effects** such as anti-inflammatory properties and plaque stabilization. *Fibric acid derivatives* - **Fibric acid derivatives** are primarily used to treat **hypertriglyceridemia** and can moderately increase HDL cholesterol, but they are less effective at lowering LDL cholesterol compared to statins. - They act by activating **PPAR-alpha**, leading to increased fatty acid oxidation and reduced triglyceride synthesis. *Nicotinic acid* - **Nicotinic acid** (niacin) is effective in **lowering triglycerides** and raising **HDL cholesterol**, but its impact on LDL cholesterol is less pronounced than statins, and it is associated with significant side effects like flushing. - It works by inhibiting hepatic VLDL synthesis and secretion, which indirectly impacts LDL formation. *Bile acid-binding resins* - **Bile acid-binding resins** reduce LDL cholesterol by binding bile acids in the intestine, leading to increased hepatic synthesis of bile acids from cholesterol and upregulation of LDL receptors. - While effective, they are generally less potent than statins and often cause **gastrointestinal side effects** such as constipation and bloating.

Q: What is the cause of cough and angioedema in a patient receiving ACE inhibitors?

Bradykinin accumulation. ***Bradykinin accumulation*** - **ACE inhibitors** block the enzyme **angiotensin-converting enzyme (ACE)**, which is responsible for degrading **bradykinin**. - The resulting **accumulation of bradykinin** is a potent vasodilator and increases capillary permeability, leading to **cough** (5-20% of patients) and **angioedema** (0.1-0.7%). - This is the most **precise answer** as it specifies the mechanism: impaired degradation leading to accumulation. *Bradykinin (alone)* - While **bradykinin** is the mediator involved, this option is **less precise** than "bradykinin accumulation." - **Bradykinin** is naturally present in the body; the problem with ACE inhibitors is specifically the **accumulation** due to impaired degradation. - The correct answer requires understanding that it's the **excess levels**, not just the presence, that causes symptoms. *Increased renin levels* - **ACE inhibitors** block the conversion of **angiotensin I to angiotensin II**, leading to reduced negative feedback. - This causes **compensatory increase in renin secretion** from the juxtaglomerular apparatus. - However, increased renin is **not responsible** for cough or angioedema—these are bradykinin-mediated effects. *Increased angiotensin-II levels* - **ACE inhibitors** actually **decrease angiotensin-II levels**, which is their primary **antihypertensive mechanism**. - This option is **incorrect** as ACE inhibitors reduce (not increase) angiotensin-II. - The reduction in angiotensin-II does not cause cough or angioedema.

Q: Which of the following drugs acts as a direct vasodilator on blood vessels?

Hydralazine. ***Hydralazine*** - **Hydralazine** is a **direct-acting vasodilator** that works by directly relaxing the smooth muscle of **arterioles**. - Unlike drugs that work through receptors or central mechanisms, hydralazine acts **directly on vascular smooth muscle** to cause relaxation. - This direct relaxation leads to a decrease in **peripheral vascular resistance**, which lowers blood pressure. - It is a prototype drug for understanding direct vasodilator mechanisms. *Verapamil* - **Verapamil** is a **non-dihydropyridine calcium channel blocker** that works by blocking L-type calcium channels. - Its vasodilatory effects are **indirect**, mediated through calcium channel blockade rather than direct smooth muscle relaxation. - Its main actions are to reduce **heart rate** and **myocardial contractility**, with secondary vasodilation. *Propranolol* - **Propranolol** is a **non-selective beta-blocker** that primarily reduces blood pressure by decreasing heart rate and myocardial contractility. - Its effects on blood vessels are **indirect**, mainly by blocking **beta-1 receptors** in the heart and **beta-2 receptors** in the vasculature. - It is not a direct vasodilator and may even cause vasoconstriction due to unopposed alpha-adrenergic effects. *Methyldopa* - **Methyldopa** is an **alpha-2 adrenergic agonist** that acts **centrally** in the brainstem to reduce sympathetic outflow. - It does not directly act on blood vessels but rather reduces peripheral vascular tone through its **central nervous system effects**. - Its mechanism is indirect, working through the CNS rather than peripheral vascular tissue.

Q: In the context of bilateral renal artery stenosis, which antihypertensive drug is considered contraindicated?

ACE inhibitors. ***ACE inhibitors*** - In bilateral renal artery stenosis, ACE inhibitors can precipitate **acute kidney injury** by severely reducing **glomerular filtration pressure**, as both kidneys rely on **angiotensin II** for maintaining this pressure [1]. - They inhibit the production of **angiotensin II**, leading to **efferent arteriolar dilation** and a drop in glomerular hydrostatic pressure, which is critical for filtration in stenosed kidneys [2]. *Beta-blockers* - Beta-blockers are generally considered safe and effective in treating hypertension associated with renal artery stenosis, as they do not directly interfere with **renal autoregulation** in the same critical way as ACE inhibitors. - They lower blood pressure by reducing **cardiac output** and inhibiting renin release but do not acutely compromise **glomerular filtration** in the presence of stenosis. *Calcium channel blockers* - Calcium channel blockers are safe to use in bilateral renal artery stenosis and are often effective in controlling blood pressure. - They dilate **afferent arterioles**, which can actually help maintain or improve **glomerular filtration rate** by increasing blood flow to the glomerulus. *Diuretics* - Diuretics can be used cautiously in renal artery stenosis to manage blood pressure and fluid overload. - However, aggressive diuresis can lead to intravascular volume depletion, which might exacerbate **renal hypoperfusion** in already stenosed kidneys.

Q: Which of the following is the traditional first-line drug used for closure of patent ductus arteriosus?

Indomethacin. ***Indomethacin*** - This **prostaglandin synthesis inhibitor** is traditionally the first-line medication used to promote closure of a **patent ductus arteriosus (PDA)** in preterm infants. - It works by inhibiting **cyclooxygenase (COX) enzymes**, thereby reducing prostaglandin E2 (PGE2) levels, which are critical for maintaining ductal patency. *Paracetamol* - While sometimes used as an alternative, **paracetamol (acetaminophen)** is not the traditional first-line drug for PDA closure. - It has a weaker effect on prostaglandin synthesis compared to NSAIDs like indomethacin. *Alprostadil* - **Alprostadil (prostaglandin E1)** is used to **maintain** the patency of the ductus arteriosus in infants with severe congenital heart defects that require a patent ductus for systemic or pulmonary blood flow. - It works in direct opposition to the goal of PDA closure. *Celecoxib* - **Celecoxib** is a **selective COX-2 inhibitor** and is not typically used for PDA closure. - Its efficacy and safety profile for this specific indication have not been established as widely as indomethacin.

Question 1

Drug used for both the acute angina attack and prophylaxis of angina:

Accepted Answer

Isosorbide dinitrate

Answer

Diltiazem

Answer

Verapamil

Answer

Dipyridamole

Question 2

Which medication is a selective beta-1 adrenergic blocker commonly used as a first-line treatment for hypertension?

Accepted Answer

Atenolol

Answer

Noradrenaline

Answer

Dopamine

Answer

Epinephrine

Question 3

Which of the following drugs is most classically associated with the coronary steal phenomenon?

Accepted Answer

Dipyridamole

Answer

Nitrates

Answer

Nicorandil

Answer

Nifedipine

Question 4

A 55-year-old patient with dyslipidemia and elevated LDL cholesterol is at increased risk of ischemic stroke. Which of the following is the most appropriate treatment to lower LDL cholesterol and reduce stroke risk?

Accepted Answer

Statins (HMG-CoA reductase inhibitors)

Answer

Nicotinic acid (niacin)

Answer

Bile acid sequestrants

Answer

Fibric acid derivatives

Question 5

Which of the following statements about Tadalafil is incorrect?

Accepted Answer

It cannot be used for the treatment of PAH

Answer

Its half life is 17.5 hours

Answer

It is used in erectile dysfunction

Answer

It is longest acting phosphodiesterase inhibitor

Question 6

For a patient diagnosed with dyslipidemia characterized by elevated LDL cholesterol levels, what is the most appropriate treatment?

Accepted Answer

Statins

Answer

Fibric acid derivatives

Answer

Nicotinic acid

Answer

Bile acid-binding resins

Question 7

What is the cause of cough and angioedema in a patient receiving ACE inhibitors?

Accepted Answer

Bradykinin accumulation

Answer

Bradykinin

Answer

Increased renin levels

Answer

Increased angiotensin-II levels

Question 8

Which of the following drugs acts as a direct vasodilator on blood vessels?

Accepted Answer

Hydralazine

Answer

Verapamil

Answer

Propranolol

Answer

Methyldopa

Question 9

In the context of bilateral renal artery stenosis, which antihypertensive drug is considered contraindicated?

Accepted Answer

ACE inhibitors

Answer

Beta-blockers

Answer

Calcium channel blockers

Answer

Diuretics

Question 10

Which of the following is the traditional first-line drug used for closure of patent ductus arteriosus?

Accepted Answer

Indomethacin

Answer

Paracetamol

Answer

Alprostadil

Answer

Celecoxib

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?